Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
14.94%
Operating Margin
-2.78%
Net Margin
-1.32%
Efficiency Metrics
Revenue per Expense Ratio
0.97
R&D as % of Revenue
2.70%
Earnings Quality
EBITDA Margin
2.80%
Income Tax Rate
34,400,000,000.0%
EPS
-1.9800000000
Balance Sheet Analysis
Current Ratio
0.94
Cash Ratio
0.05
Working Capital
$-1.88B
Debt to Equity
0.16
Debt to Assets
2.57%
Equity Ratio
16.08%
Cash Flow Analysis
Operating Cash Flow Ratio
3.57%
Free Cash Flow Ratio
1.33%
CapEx to Revenue
2.24%
Dividends Paid
No dividends paid
Stock Buybacks
No buybacks
Total Shareholder Returns
No shareholder returns
Cash Position Change
-24.96%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
12.09%
Net Income
83.99%
EPS
80.32%
Operating Income
47.05%
Operational Efficiency
R&D Expenses
-8.48%
SG&A Expenses
9.76%
Operating Cash Flow
1,140.35%
Free Cash Flow
170.49%
Balance Sheet Health
Assets
3.71%
Debt
1.37%
Book Value per Share
-27.80%
Inventory
6.72%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
0.71%
5Y Revenue/Share
0.71%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%